JP2005529904A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2005529904A5 JP2005529904A5 JP2004500865A JP2004500865A JP2005529904A5 JP 2005529904 A5 JP2005529904 A5 JP 2005529904A5 JP 2004500865 A JP2004500865 A JP 2004500865A JP 2004500865 A JP2004500865 A JP 2004500865A JP 2005529904 A5 JP2005529904 A5 JP 2005529904A5
- Authority
- JP
- Japan
- Prior art keywords
- pharmaceutical composition
- ethylphenyl
- triazole
- methoxyphenyl
- uveitis
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000008194 pharmaceutical composition Substances 0.000 claims 4
- NAUNDFHXCIMBKS-UHFFFAOYSA-N 1-[3-(2-ethylphenyl)-5-methoxyphenyl]-1,2,4-triazole Chemical compound CCC1=CC=CC=C1C1=CC(OC)=CC(N2N=CN=C2)=C1 NAUNDFHXCIMBKS-UHFFFAOYSA-N 0.000 claims 2
- 241000124008 Mammalia Species 0.000 claims 2
- 208000023275 Autoimmune disease Diseases 0.000 claims 1
- 210000001744 T-lymphocyte Anatomy 0.000 claims 1
- 206010046851 Uveitis Diseases 0.000 claims 1
- 230000005764 inhibitory process Effects 0.000 claims 1
- 201000006417 multiple sclerosis Diseases 0.000 claims 1
- 206010039073 rheumatoid arthritis Diseases 0.000 claims 1
- 201000000596 systemic lupus erythematosus Diseases 0.000 claims 1
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US10/137,699 US6797722B2 (en) | 2002-05-03 | 2002-05-03 | Use of 3-(2-ethylphenyl)-5-(3-methoxyphenyl)-1H-1,2,4-triazole for the treatment of autoimmune diseases |
| PCT/IT2003/000237 WO2003092681A1 (en) | 2002-05-03 | 2003-04-15 | Use of (3-(2-ethylphenyl)-5-methoxyphenyl)-1h-[1,2,4]-triazole for the treatment of autoimmune diseases |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2005529904A JP2005529904A (ja) | 2005-10-06 |
| JP2005529904A5 true JP2005529904A5 (https=) | 2006-06-08 |
Family
ID=29269138
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2004500865A Pending JP2005529904A (ja) | 2002-05-03 | 2003-04-15 | 自己免疫疾患の治療のための（３−（２−エチルフェニル）−５−メトキシフェニル）−１ｈ−［１，２，４］−トリアゾールの使用 |
Country Status (15)
| Country | Link |
|---|---|
| US (2) | US6797722B2 (https=) |
| EP (1) | EP1501505B1 (https=) |
| JP (1) | JP2005529904A (https=) |
| KR (1) | KR20040111491A (https=) |
| AT (1) | ATE315935T1 (https=) |
| AU (1) | AU2003224453A1 (https=) |
| CA (1) | CA2483904A1 (https=) |
| DE (1) | DE60303296T2 (https=) |
| DK (1) | DK1501505T3 (https=) |
| ES (1) | ES2257666T3 (https=) |
| MX (1) | MXPA04010785A (https=) |
| PL (1) | PL374252A1 (https=) |
| PT (1) | PT1501505E (https=) |
| TW (1) | TWI284532B (https=) |
| WO (1) | WO2003092681A1 (https=) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| MY142651A (en) * | 2003-03-18 | 2010-12-15 | Merck Sharp & Dohme | Biaryl substituted triazoles as sodium channel blockers |
| WO2005077411A2 (en) * | 2004-02-10 | 2005-08-25 | Innate Pharma | Composition and method for the treatment of carcinoma |
| EP1921073A1 (en) | 2006-11-10 | 2008-05-14 | Laboratorios del Dr. Esteve S.A. | 1,2,4-Triazole derivatives as sigma receptor inhibitors |
Family Cites Families (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4379155A (en) * | 1979-06-11 | 1983-04-05 | Gruppo Lepetit S.P.A. | 3,5-Disubstituted-1H-1,2,4-triazole derivatives |
| JPS58126810A (ja) * | 1981-12-24 | 1983-07-28 | Kaken Pharmaceut Co Ltd | 抗炎症眼科用液剤およびその製法 |
| DE3808283A1 (de) * | 1988-03-12 | 1989-09-21 | Boehringer Ingelheim Kg | Neue 3,4,5-substituierte 4h-1,2,4-triazole, ihre herstellung und verwendung |
| US4895872A (en) * | 1989-03-15 | 1990-01-23 | Cetus Corporation | Immunosupressive analogues and derivatives of succinylacetone |
| US5273979A (en) * | 1991-08-01 | 1993-12-28 | Merck & Co., Inc. | C-31 desmethyl FR-900520 cyclic hemiketal immunosuppressant agent |
| US5189042A (en) * | 1991-08-22 | 1993-02-23 | Merck & Co. Inc. | Fluoromacrolides having immunosuppressive activity |
| US5484788A (en) * | 1993-03-26 | 1996-01-16 | Beth Israel Hospital Association | Buspirone as a systemic immunosuppressant |
| DE4320801A1 (de) * | 1993-06-23 | 1995-01-05 | Fahlberg List Pharma Gmbh | 2-Hydroxyphenylsubstituierte 1,2,4-Triazole und 1,2,4-Oxadiazole, ihre Verwendung als pharmazeutische Wirkstoffe und sie enthaltende Arzneimittel |
| AU4385696A (en) * | 1996-01-18 | 1997-08-11 | Christian Gronhoj Larsen | Synthetic il-10 analogues |
| ATE298740T1 (de) * | 1997-04-04 | 2005-07-15 | Mitsubishi Pharma Corp | 2-aminopropan-1,3-diol-verbindungen, ihre medizinische anwendung und zwischenprodukte zu ihrer synthese |
| IT1292092B1 (it) * | 1997-06-05 | 1999-01-25 | Geange Ltd | Impiego di derivati eterociclici aromatici azotati nel trattamento topico di affezioni di tessuti epiteliali |
| EP1099695A1 (en) * | 1999-11-09 | 2001-05-16 | Laboratoire Theramex S.A. | 5-aryl-1H-1,2,4-triazole compounds as inhibitors of cyclooxygenase-2 and pharmaceutical compositions containing them |
-
2002
- 2002-05-03 US US10/137,699 patent/US6797722B2/en not_active Expired - Fee Related
-
2003
- 2003-04-15 PT PT03720879T patent/PT1501505E/pt unknown
- 2003-04-15 JP JP2004500865A patent/JP2005529904A/ja active Pending
- 2003-04-15 PL PL03374252A patent/PL374252A1/xx not_active Application Discontinuation
- 2003-04-15 KR KR10-2004-7015884A patent/KR20040111491A/ko not_active Ceased
- 2003-04-15 WO PCT/IT2003/000237 patent/WO2003092681A1/en not_active Ceased
- 2003-04-15 AT AT03720879T patent/ATE315935T1/de not_active IP Right Cessation
- 2003-04-15 EP EP03720879A patent/EP1501505B1/en not_active Expired - Lifetime
- 2003-04-15 AU AU2003224453A patent/AU2003224453A1/en not_active Abandoned
- 2003-04-15 ES ES03720879T patent/ES2257666T3/es not_active Expired - Lifetime
- 2003-04-15 DK DK03720879T patent/DK1501505T3/da active
- 2003-04-15 CA CA002483904A patent/CA2483904A1/en not_active Abandoned
- 2003-04-15 MX MXPA04010785A patent/MXPA04010785A/es active IP Right Grant
- 2003-04-15 DE DE60303296T patent/DE60303296T2/de not_active Expired - Fee Related
- 2003-04-22 TW TW092109389A patent/TWI284532B/zh not_active IP Right Cessation
-
2004
- 2004-03-30 US US10/812,308 patent/US20050026980A1/en not_active Abandoned
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EP1622742A4 (en) | CMP COMPOSITIONS FOR STEP II COPPER EQUIPMENT AND OTHER ASSOCIATED MATERIALS AND USE METHOD THEREFOR | |
| NO20070973L (no) | Antagonisering av interleukin-21 reseptoraktivitet | |
| AU2003226014A1 (en) | Histone deacetylase inhibitors for the treatment of multiple sclerosis, amyotrophic lateral sclerosis and alzheimer's disease | |
| CA2289851A1 (en) | Compounds and methods for the inhibition of the expression of vcam-1 | |
| EP1631269A4 (en) | METHOD AND COMPOSITIONS FOR DISTRIBUTING CATECHOLIC BUTANESE FOR THE TREATMENT OF ADIPOSITAS | |
| JP2004538039A5 (https=) | ||
| EP1943669A4 (en) | LINEAR AND NETWORKED HIGHLY MOLECULAR POLYSILANES, POLYGERMANES AND COPOLYMERS THEREOF, COMPOSITIONS CONTAINING THEM AND METHOD FOR THE PREPARATION AND USE OF SUCH COMPOUNDS AND COMPOSITIONS | |
| IS6727A (is) | Bíhringtengd pýrrólýlamíð sem glúkógenfosfórýlasahemlar | |
| EP1636250A4 (en) | SELF-ORGANIZING PEPTIDES CONTAINING MODIFICATIONS AND METHOD FOR THEIR USE | |
| EP1951272A4 (en) | USE OF LACTOBACILLUS FOR THE TREATMENT OF VIRUS INFECTIONS | |
| WO2002066012A3 (de) | Amphotere liposomen und verwendung dieser | |
| JP2001512767A5 (https=) | ||
| JP2007511047A5 (https=) | ||
| JPH101422A5 (https=) | ||
| NO20053773D0 (no) | Parentale peptidformuleringer for behandling av systemisk lupus erytematosus | |
| JP2005529904A5 (https=) | ||
| WO2007140011A3 (en) | Erythroid progenitor cells and methods for producing parvovirus b19 therein | |
| EP1449860A4 (en) | NEW FLUOROPOLYMER, THESE RESISTANT COMPOSITIONS, AND NEW FLUORMONOMERS | |
| NO20071399L (no) | VLA-4-antagonister | |
| JP2004315516A5 (https=) | ||
| FR2831732B1 (fr) | Fourniture d'images numeriques geolocalisees personnalisees | |
| FR2835851B1 (fr) | Composition pour le traitement d'alliages de magnesium | |
| JP2005532458A5 (https=) | ||
| NO20025964L (no) | Ny interferon for behandling av multippel sklerose | |
| FR2857527B1 (fr) | Compression contextuelle d'images numeriques |